Novartis to acquire radioligand therapeutics firm Mariana for $1.75bn

By NS Healthcare Staff Writer 03 May 2024

Mariana Oncology is a preclinical-stage biotechnology company focused on developing novel radioligand therapies (RLTs) to treat cancers, and the acquisition encompasses a portfolio of RLT programs across a range of solid tumour indications

three-flags-fly-outside-a-novartis-manufacturing-facility

Pharmaceuticals

Novartis to acquire radioligand therapeutics firm Mariana for $1.75bn

Bayer Pharmaceuticals takes full ownership of Bayer Zydus....

Poseida secures cell therapies deal worth up to....

BridgeBio launches BridgeBio Oncology Therapeutics with $200m funding

Bruker Completes Acquisition of Molecular Diagnostics Innovator ELITech

Pharmaceuticals

Astellas, Poseida partner to develop allogeneic cell therapies for cancer
02 May 24

BioCardia’s CardiAMP Cell Therapy shows patient benefits in chronic myocardial ischemia trial
02 May 24

Editas Medicine, Bristol Myers Squibb extend T cell therapy partnership
02 May 24

Patient Care

Alkermes Completes Sale of Athlone, Ireland Facility to Novo Nordisk
03 May 24

QIAGEN enhances bioinformatics workflows with new secondary analysis solution for oncology and inherited disease applications
03 May 24

Boehringer Ingelheim gets FDA approval for high-concentration formulation of Cyltezo
02 May 24

Nutraceuticals

Goli Nutrition Introduces New Matcha Mind Cognitive Gummies Launched Nationwide at Target
03 May 24

Nestlé India and Dr. Reddy’s to form joint venture to take health science nutraceutical portfolio to consumers across India and other agreed territories
26 Apr 24

Squalene Shows Promise in Reducing Mortality and Re-hospitalization Among COVID-19 Subjects
05 Apr 24

NS Healthcare is using cookies

Astellas, Poseida partner to develop allogeneic cell therapies for cancer02 May 24

BioCardia’s CardiAMP Cell Therapy shows patient benefits in chronic myocardial ischemia trial02 May 24

Editas Medicine, Bristol Myers Squibb extend T cell therapy partnership02 May 24

Alkermes Completes Sale of Athlone, Ireland Facility to Novo Nordisk 03 May 24

QIAGEN enhances bioinformatics workflows with new secondary analysis solution for oncology and inherited disease applications 03 May 24

Boehringer Ingelheim gets FDA approval for high-concentration formulation of Cyltezo 02 May 24

Goli Nutrition Introduces New Matcha Mind Cognitive Gummies Launched Nationwide at Target03 May 24

Nestlé India and Dr. Reddy’s to form joint venture to take health science nutraceutical portfolio to consumers across India and other agreed territories26 Apr 24

Squalene Shows Promise in Reducing Mortality and Re-hospitalization Among COVID-19 Subjects05 Apr 24

OUR TITLES

New Study Shows Copan’s Colibrí™ Automates....02 May 24

Oxford Properties starts work on Ionis....06 Dec 23

Healthpeak to merge with Physicians Realty....31 Oct 23

PepsiCo Beverage’s Sacramento-Based Electric Fleet Is....29 Sep 23

Japan’s ONO Pharmaceutical to acquire Deciphera....30 Apr 24

Perrigo to divest HRA Pharma Rare....26 Apr 24

Incyte to acquire Escient Pharmaceuticals for....24 Apr 24

Lilly acquires new injectable medicine manufacturing....23 Apr 24

Neomorph, Novo Nordisk enter $1.46bn partnership....27 Feb 24

AbbVie, Tentarix partner to develop oncology....23 Feb 24

General Dynamics unit wins $2.5bn contract....14 Nov 23

SGC, HitGen collaborate on DEL technology....29 Sep 23

Astellas, Poseida partner to develop allogeneic cell therapies for cancer
02 May 24

BioCardia’s CardiAMP Cell Therapy shows patient benefits in chronic myocardial ischemia trial
02 May 24

Editas Medicine, Bristol Myers Squibb extend T cell therapy partnership
02 May 24

Alkermes Completes Sale of Athlone, Ireland Facility to Novo Nordisk
03 May 24

QIAGEN enhances bioinformatics workflows with new secondary analysis solution for oncology and inherited disease applications
03 May 24

Boehringer Ingelheim gets FDA approval for high-concentration formulation of Cyltezo
02 May 24

Goli Nutrition Introduces New Matcha Mind Cognitive Gummies Launched Nationwide at Target
03 May 24

Nestlé India and Dr. Reddy’s to form joint venture to take health science nutraceutical portfolio to consumers across India and other agreed territories
26 Apr 24

Squalene Shows Promise in Reducing Mortality and Re-hospitalization Among COVID-19 Subjects
05 Apr 24

New Study Shows Copan’s Colibrí™ Automates....
02 May 24

Oxford Properties starts work on Ionis....
06 Dec 23

Healthpeak to merge with Physicians Realty....
31 Oct 23

PepsiCo Beverage’s Sacramento-Based Electric Fleet Is....
29 Sep 23

Japan’s ONO Pharmaceutical to acquire Deciphera....
30 Apr 24

Perrigo to divest HRA Pharma Rare....
26 Apr 24

Incyte to acquire Escient Pharmaceuticals for....
24 Apr 24

Lilly acquires new injectable medicine manufacturing....
23 Apr 24

Neomorph, Novo Nordisk enter $1.46bn partnership....
27 Feb 24

AbbVie, Tentarix partner to develop oncology....
23 Feb 24

General Dynamics unit wins $2.5bn contract....
14 Nov 23

SGC, HitGen collaborate on DEL technology....
29 Sep 23